Acasti Pharma Inc. Share Price Toronto S.E.
Equities
ACST
CA00430K8730
Pharmaceuticals
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.44M 25.9M 2.16B |
---|---|---|---|---|---|
Net income 2024 * | -18M -13.15M -1.1B | Net income 2025 * | -23M -16.81M -1.4B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.95
x | P/E ratio 2025 * |
-2.51
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc.
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/21/01 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/23/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10/23/10 |
Director/Board Member | - | 10/23/10 | |
Santosh Kottayil
BRD | Director/Board Member | - | 10/23/10 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |